Product Recalls: September 12, 2018 – October 10, 2018

Health Letter, November 2018

CLASS I

Hydrochlorothiazide tablets, 12.5 mg, 100-count bottle. Manufactured for: Accord Healthcare, Inc.

Robaxin-750 (methocarbamol) tablets, 750 mg, 100-count bottle. Distributed by: Endo Pharmaceuticals Inc. Manufactured by: Kremers Urban Pharmaceuticals Inc.

CLASS II

Clozapine orally disintegrating tablets, 12.5 mg, 100-count bottles. Manufactured by: Teva Pharmaceuticals USA, Inc.

Lamotrigine extended-release tablets, 200 mg, 30-count bottle. Manufactured for: Torrent Pharma Inc.

Montelukast sodium tablets, 10 mg, 30-count bottles. By: Hetero, Hetero Labs Limited.

Synjardy (empagliflozin and metformin hydrochloride) tablets, 5 mg/1000 mg, 180-count bottle. Distributed by: Boehinger Ingelheim (BI) Pharmaceuticals, Inc.

Tizanidine HCl tablets, 2 mg, 150-count bottles. Manufactured by: Dr. Reddy’s Laboratories Limited.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.

CONSUMER PRODUCTS

For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.